Filing Details

Accession Number:
0001104659-22-128768
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-20 20:01:10
Reporting Period:
2022-12-16
Accepted Time:
2022-12-20 20:01:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1571934 Synaptogenix Inc. SNPX Pharmaceutical Preparations (2834) 461585656
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1686138 L. Daniel Alkon C/O Synaptogenix, Inc., 1185 Avenue
Of The Americas, 3Rd Floor
New York NY 10036
President And Cso Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Per Share Disposition 2022-12-16 19,688 $1.17 35,546 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Shares sold pursuant to a Rule 10b5-1 sales plan, entered into on December 6, 2021 and amended and restated on October 24, 2022, to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.